Synapse - Heather Landau

Results (433)

Effect of conditioning regimen dose reduction in obese patients undergoing autologous hematopoietic cell transplantation

Journal Article

Brunstein, C. G.; Pasquini, M. C.; Kim, S.; Fei, M.; Adekola, K.; Ahmed, I.; Aljurf, M.; Agrawal, V.; Auletta, J. J.; Battiwalla, M.; more...
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Autologous transplantation, consolidation, and maintenance therapy in multiple myeloma: Results of the BMT CTN 0702 Trial

Journal Article

Stadtmauer, E. A.; Pasquini, M. C.; Blackwell, B.; Hari, P.; Bashey, A.; Devine, S.; Efebera, Y.; Ganguly, S.; Gasparetto, C.; Geller, N.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Vemurafenib in patients with relapsed refractory multiple myeloma harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study

Journal Article

Raje, N.; Chau, I.; Hyman, D. M.; Ribrag, V.; Blay, J. Y.; Tabernero, J.; Elez, E.; Wolf, J.; Yee, A. J.; Kaiser, M.; more...
JCO Precision Oncology (2018)

Fulltext@MSK | Save

Dysgeusia is associated with higher melphalan pharmacokinetic levels and results in poorer caloric intake and worse symptom burden after autologous stem cell transplantation for multiple myeloma

Meeting Abstract

Scordo, M.; Shah, G. L.; Preston, E. V.; Rodriguez, N.; Lin, A.; Maloy, M.; Mastrogiacomo, B.; Carlow, D.; Schofield, R.; Knezevic, A.; more...
Blood (2018)

Fulltext@MSK | Save

Impact of CD34 cell dose infused on the duration of absolute neutropenia after high dose melphalan and autologous HCT for myeloma

Meeting Abstract

Bachier Rodriguez, L.; Shah, G. L.; Knezevic, A.; Devlin, S. M.; Maloy, M.; Koehne, G.; Chung, D. J.; Landau, H. J.; Giralt, S.
Blood (2018)

Fulltext@MSK | Save

Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial

Meeting Abstract

Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
Blood (2018)

Fulltext@MSK | Save

Homebound autologous hematopoietic cell transplantation for plasma cell disorders in an urban setting is safe for patients and preferred by patients and caregivers

Meeting Abstract

Landau, H. J.; Shah, G. L.; Reeds, M.; Hilden, P.; Andrejko, M.; Applebaum, A.; Batalha, J.; Cazeau, N.; Chung, D. J.; Cortes, M.; more...
Blood (2018)

Fulltext@MSK | Save

MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone